期刊文献+

己酮可可碱治疗重症酒精性肝炎的疗效观察 被引量:4

下载PDF
导出
摘要 目的比较己酮可可碱和强的松龙治疗重症酒精性肝炎的疗效和药物副作用。方法将符合纳入标准的重症酒精性肝炎患者随机分成己酮可可碱组和强的松龙组,比较两组的死亡率及入选时及治疗3月后肝功能、肾功能、凝血功能、Maddrey判别函数等指标的变化,最后比较两组的副作用。结果己酮可可碱组死亡率(11.11%)显著低于强的松龙组(27.78%),差异有统计学意义(P<0.01);治疗后己酮可可碱组ALT、INR、MDF、总胆红素、血肌酐、CRP和TNF-α等水平显著低于治疗前,差异有统计学意义(P<0.01);强的松龙组治疗前后上述指标比较无统计学差异;己酮可可碱组治疗后上述指标显著低于强的松龙组,差异有统计学意义(P<0.01);两组均出现恶心、呕吐、消化不良等消化系统副作用,己酮可可碱发生率更高,但却未出现糖耐量异常的副作用;己酮可可碱组无合并肝肾综合征、消化道出血和脑病等严重并发症患者,强的松龙组可见这些严重的并发症。结论己酮可可碱在治疗重症酒精性肝炎具有更好疗效和更少副作用。
作者 林雅
出处 《海峡药学》 2011年第11期102-103,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献4

  • 1厉有名,范建高,王炳元,陆伦根,施军平,牛俊奇,沈薇,徐有青.酒精性肝病诊疗指南(2010年1月修订)[J].现代医药卫生,2011,27(6):801-804. 被引量:62
  • 2Lee KS, Cottam HIS, Houglum K, et al. Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity [J]. Am J Physiol, 1997, 273 : G1094-G1100.
  • 3Zhao XJ, Dong Q, Bind,as J, et aI.TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol [J] . J Immunol, 2008, 181 : 3049-3056.
  • 4Windmeier C, Gressner AM. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis [J]. Gen Pharmacol, 1997, 29:181-196.

二级参考文献15

共引文献61

同被引文献33

  • 1Sarpreet Basra,Bhupinderjit S Anand.Definition,epidemiology and magnitude of alcoholic hepatitis[J].World Journal of Hepatology,2011,3(5):108-113. 被引量:11
  • 2张晓燕,陈丽红,管又飞.PPAR家族及其与代谢综合征的关系[J].生理科学进展,2005,36(1):6-12. 被引量:38
  • 3Leung TM,Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol,2013,58(2): 395-398.
  • 4Crabb DW,Galli A,Fischer M,et al. Molecular mechanisms of alcoholic fatty liver:role of peroxisome proliferator-activated receptor alpha. Alcohol,2004,34(1):35-38.
  • 5Anji A,Kumari M. Supplementing the liquid alcohol diet withchow enhances alcohol intake in C57 BIJ6 mice. Drug Alcohol Depend, 2008,97( 1-2):86-93.
  • 6Mendes JB,Campos PP,Rocha MA,et al. Cilostazol and pentoxifylline decrease angiogenesis, inflammation, and fibrosis in sponge-induced intraperitoneal adhesion in mice. Life Sci, 2009,84( 15-16 ):537-543.
  • 7Zhu H,Jia Z,Misra H,et al. Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence. J Dig Dis, 2012,13(3): 133-142.
  • 8Liu X,Bastian S,Snow CD,et al. Structure-guided engineering of laetococcus laetis alcohol dehydrogenase L1AdhA for im- proved conversion of isobutyraldehyde to isobutanol. J Biotech- nol,2012, 164(2):188-195.
  • 9Wang Y, Millonig G, Nair J, et al. Ethanol-induced cytochrome P4502E1 causes careinogenie etheno-DNA lesions in alcoholic liver disease. Hepatology,2009,50(2):453-461.
  • 10Vidali M,Stewart SF,Rolla R,et al. Genetic and epigenetie factors in autoimmune reactions toward eytochrome P4502E1 in alcoholic liver disease. Hepatology,2003,37(2):410-419.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部